Atlas Trials

2- Day vs. 5- Day Terlipressin and Ceftriaxone in the Control Acute Gastroesophageal Variceal Hemorrhage

Clinical trial NCT04056806 · UNKNOWN

Trial details

NCT number
NCT04056806
Sponsor
E-DA Hospital
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Variceal Rebleeding Rate and Infections
Start date
2019-08-01
Primary completion
2022-06-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.